Patents Assigned to Pronata N.V.
  • Method of treating renal dysfunction based on perlecan as a biomarker
    Patent number: 8501418
    Abstract: The application discloses PERLECAN as a new biomarker for renal dysfunction; methods for predicting, diagnosing, prognosticating and/or monitoring said dysfunction based on measuring said biomarker; and kits and devices for measuring said biomarker and/or performing said methods.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: August 6, 2013
    Assignee: Pronata N.V.
    Inventors: Koen Kas, Griet Vanpoucke, Piet Moerman